These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38555157)

  • 1. Isolation of myeloid-derived suppressor cells (MDSC) from endometriotic mice model and their immunomodulatory functions.
    Song Y; Liu Y; Xu Q; Leung KT; Chan LKY; Chung JPW; Wang CC; Chen X; Zhang T; Man GCW
    Methods Cell Biol; 2024; 184():33-57. PubMed ID: 38555157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis.
    He Y; Hung SW; Liang B; Zhang R; Gao Y; Chu CY; Zhang T; Xu H; Chung JPW; Wang CC
    Front Immunol; 2021; 12():641206. PubMed ID: 34367125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target.
    Zhang T; Zhou J; Man GCW; Leung KT; Liang B; Xiao B; Ma X; Huang S; Huang H; Hegde VL; Zhong Y; Li Y; Kong GWS; Yiu AKW; Kwong J; Ng PC; Lessey BA; Nagarkatti PS; Nagarkatti M; Wang CC
    Eur J Immunol; 2018 Jun; 48(6):1059-1073. PubMed ID: 29460338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Characterization and Isolation of Myeloid-Derived Suppressor Cells.
    Reuven O; Mikula I; Ashkenazi-Preiser H; Twaik N; Ben-Meir K; Meirow Y; Daniel L; Kariv G; Kurd M; Baniyash M
    Curr Protoc; 2022 Oct; 2(10):e561. PubMed ID: 36214619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5/CCR5 ligand-induced myeloid-derived suppressor cells are related to the progression of endometriosis.
    Guo P; Bi K; Lu Z; Wang K; Xu Y; Wu H; Cao Y; Jiang H
    Reprod Biomed Online; 2019 Oct; 39(4):704-711. PubMed ID: 31427176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art.
    Suszczyk D; Skiba W; Jakubowicz-Gil J; Kotarski J; Wertel I
    Cells; 2021 Mar; 10(3):. PubMed ID: 33803806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An In Vivo Mouse Model for Chronic Inflammation-Induced Immune Suppression: A "Factory" for Myeloid-Derived Suppressor Cells (MDSCs).
    Ben-Meir K; Twaik N; Meirow Y; Baniyash M
    Curr Protoc; 2022 Sep; 2(10):e558. PubMed ID: 36239438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cells: A new emerging player in endometriosis.
    Zhang T; He Y; Man GCW; Ding Y; Wang CC; Chung JPW
    Int Rev Cell Mol Biol; 2023; 375():191-220. PubMed ID: 36967153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of polymorphonuclear myeloid-derived suppressor cells in endometriosis.
    Satake E; Koga K; Takamura M; Izumi G; Elsherbini M; Taguchi A; Makabe T; Takeuchi A; Harada M; Hirata T; Hirota Y; Wada-Hiraike O; Osuga Y
    J Reprod Immunol; 2021 Nov; 148():103371. PubMed ID: 34517223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator.
    Oliver L; Alvarez R; Diaz R; Valdés A; Colligan SH; Nemeth MJ; Twum DYF; Fernández A; Fernández-Medina O; Carlson LM; Yu H; Eng KH; Hensen ML; Rábade-Chediak ML; Fernández LE; Lee KP; Perez L; Muhitch JB; Mesa C; Abrams SI
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36150744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-Derived Suppressor Cells in Lung Transplantation.
    Heigl T; Singh A; Saez-Gimenez B; Kaes J; Van Herck A; Sacreas A; Beeckmans H; Vanstapel A; Verleden SE; Van Raemdonck DE; Verleden G; Vanaudenaerde BM; Hartl D; Vos R
    Front Immunol; 2019; 10():900. PubMed ID: 31080450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients.
    Bruderek K; Schirrmann R; Brandau S
    Methods Mol Biol; 2021; 2236():1-7. PubMed ID: 33237535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Assays Evaluating Immunosuppression Mediated by Myeloid-Derived Suppressor Cells.
    Reuven O; Mikula I; Ashkenazi-Preiser H; Twaik N; Ben-Meir K; Meirow Y; Daniel L; Kariv G; Kurd M; Baniyash M
    Curr Protoc; 2022 Oct; 2(10):e557. PubMed ID: 36282094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and Phenotyping of Splenic Myeloid-Derived Suppressor Cells in Murine Cancer Models.
    Sanseviero E; Kim R; Gabrilovich DI
    Methods Mol Biol; 2021; 2236():19-28. PubMed ID: 33237537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
    Wang L; Hu D; Xie B; Xie L
    Invest New Drugs; 2022 Jun; 40(3):506-518. PubMed ID: 35089465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
    Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
    mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
    Binsfeld M; Muller J; Lamour V; De Veirman K; De Raeve H; Bellahcène A; Van Valckenborgh E; Baron F; Beguin Y; Caers J; Heusschen R
    Oncotarget; 2016 Jun; 7(25):37931-37943. PubMed ID: 27177328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aryl hydrocarbon receptor activation drives polymorphonuclear myeloid-derived suppressor cell response and efficiently attenuates experimental Sjögren's syndrome.
    Wei Y; Peng N; Deng C; Zhao F; Tian J; Tang Y; Yu S; Chen Y; Xue Y; Xiao F; Zhou Y; Li X; Zou H; Rui K; Lin X; Lu L
    Cell Mol Immunol; 2022 Dec; 19(12):1361-1372. PubMed ID: 36369368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of Myeloid-Derived Suppressor Cells, Chronic Inflammatory Cytokines, and Exosomal miRNA Contribute to the Peritoneal Immune Disorder of Patients With Endometriosis.
    Chen Y; Wang K; Xu Y; Guo P; Hong B; Cao Y; Wei Z; Xue R; Wang C; Jiang H
    Reprod Sci; 2019 Aug; 26(8):1130-1138. PubMed ID: 30453861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.